ParkerVision Q2 net loss $0.3M vs year-ago net income; patent litigation updates

PARKERVISION INC

2024-Q2 EPS reported -$0.01

Net loss of $0.3M ($0.00 per share) for Q2 2024 vs net income of $1.4M ($0.02) in Q2 2023.
First-half 2024 net loss $1.0M ($0.01 per share) vs net income $14.5M ($0.17) in H1 2023, which included a $25M patent settlement.
Cash used in operations $1.4M in H1 2024; ended Q2 with $1.0M cash.
CAFC jurisdiction resolved; Qualcomm appeal resubmitted August 7, 2024; decision awaited.
Jury trials scheduled in Texas starting March 2025 against Realtek, MediaTek, TI, NXP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.